Gene Discovery News: Breaking Gene Discovery News, Comments and Articles. - Page: 5

03:27 EDT 4th August 2015 | BioPortfolio

Gene Discovery News - Page: 5RSS

Read the latest Gene Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Discovery.

Search or Follow Our Gene Discovery - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Discovery - Page: 5 News.

Showing "gene discovery" News Articles 101 to 125 of 7,000+

Thursday 30th July 2015

The 26th Neuronal Plasticity Prize of the Fondation Ipsen has been awarded to

Mark F. Bear (Massachusetts Institute of Technology, Cambridge, USA)David J. Porteous (University of Edinburgh, Edinburgh, UK) andThomas Bourgeron (Institut Pasteur - CNRS, Paris, France) The 26th Neuronal Plasticity Prize of the Fondation Ipsen has been awarded to three scientists for their pioneering work in the domain of genes, syna...

Genkyotex’s NOX1&4 Inhibitor Strategy in Liver Fibrosis Supported by New Preclinical Results

Research Conducted by Leading Academic Labs Further Elucidates Fundamental Role of NOX Enzymes in Fibrosis Genkyotex, the leading developer of selective NOX inhibitors, announced today publication of results from two independent studies confirming the important role played by both NOX1 and NOX4 enzymes in the development of liver fibrosis. This researc...

Discovery prompts rethink on metals and Alzheimer's disease

Researchers at the University of Melbourne have discovered that a protein involved in the progression of Alzheimer's disease also has properties that could be helpful for human health.

Gut bacteria hold the key to infant liver development and drug metabolism

The liver plays a critical role in human metabolism. As the gatekeeper of the digestive track, this massive organ is responsible for drug breakdown and is therefore the first to be injured due to overdose or misuse. Evaluating this drug-induced liver...

Expanding the brain: Research identifies more than 40 new imprinted genes

It's among the cornerstones of biology: All mammals inherit two copies ― one from their mother, the other from their father—of every gene, in part to act as a backstop against genetic problems. If a gene is damaged or malfunctions, its double can...

Certara Launches Its Simcyp In Vitro Data Analysis Toolkit

This new standalone solution is designed to meet the needs of early-stage drug discovery and development researchers. Date:  Thu, 2015-07-30 (All day) read more

Wednesday 29th July 2015

Real-time observation of interfering crystal electrons in high-harmonic generation

Acceleration and collision of particles has been a key strategy for exploring the texture of matter. Strong light waves can control and recollide electronic wavepackets, generating high-harmonic radiation that encodes the structure and dynamics of at...

Theravance Biopharma to Present at the Wedbush PacGrow Healthcare Conference

DUBLIN, IRELAND -- (Marketwired) -- 07/30/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that Rick E Winningham, Chairman and Chief Executive Officer, is scheduled to present at the Wedbush PacGrow Healthcare Conference on Wednesday, August 12, 2015, at 1:55 p.m. ET. The conference will be held from August 11-12 at the Le Meridien, New Yo...

Engineered CHO cell platform for producing biologics with human-like glycosylation patterns

A panel of gene-edited CHO cells with altered

Scientists create functional liver cells from stem cells

(The Hebrew University of Jerusalem) Evaluating drug-induced liver injury is a critical part of pharmaceutical drug discovery and must be carried out on human liver cells. Now, in research published on the cover of Hepatology journal, Hebrew Universi...

Safeguarding the greater good

(Wyss Institute for Biologically Inspired Engineering at Harvard) Research teams from the Wyss Institute and University of California, San Diego -- the only two groups to have published work on RNA-guided CRISPR gene drives -- have proactively assemb...

Cell aging slowed by putting brakes on noisy transcription

(University of Pennsylvania School of Medicine) Working with yeast and worms, researchers found that incorrect gene expression is a hallmark of aged cells and that reducing such 'noise' extends lifespan in these organisms.

Discovery about brain protein causes rethink on development of Alzheimer's disease

(University of Melbourne) Researchers at the University of Melbourne have discovered that a protein involved in the progression of Alzheimer's disease also has properties that could be helpful for human health.

Dicerna to Announce Second Quarter 2015 Financial Results and Host Conference Call on August 6, 2015

Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNA interference-based therapeutics targeting rare inherited diseases involving the liver and for cancers that are genetically defined, announced that the Company will release its second quarter 2015 financial results after market close on Thursday, August 6, 2015. ...

Deerfield Management’s Jim Flynn on CRISPR, and that $550M new fund

CRISPR gene editing technology is one of the most intriguing growth fields in biotech, says Deerfield Management president Jim Flynn. The venture firm just launched a new $550 million fund, and it'll focus on seeding startups and funding new companie...

Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients

PARSIPPANY, N.J. and BERKELEY, Calif., July 29, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc. and Plexxikon Inc., a member of the Daiichi Sankyo Group, announced today that The New England Journal of Medicine (NEJM) published clinical trial results demonstrating that the investigational drug, PLX3397, an oral targeted CSF-1R inhibitor, induced prolonged tumor regressions in most patients with tenosyno...

GM Rice Produces High Yield, Less GHG Emissions

Swedish University of Agricultural Sciences researcher Chuanxin Sun and team from different institutions developed rice plants producing higher yields and lesser greenhouse-gas (GHG) emissions. The results of their study were published in Nature. The new rice variety was engineered to express a gene from barley, which makes the plant produce lesser...

OGTR Receives License Application for Commercial Release of GM Canola

The Office of the Gene Technology Regulator (OGTR) has received a license application (DIR 139) from Pioneer Hi-Bred Australia for commercial cultivation of genetically modified (GM) canola. DIR 139 is for commercial release of the herbicide tolerant GM canola variety Optimum™ GLY. Pioneer is seeking approval to cultivate the GM canola in all canol...

Overexpression of Stress-Associated Protein from Rice Increases Salt Tolerance in Arabidopsis

The stress-associated protein (SAP) family has been found to provide salinity stress tolerance in plants. Zamri Zainal of the Universiti Kebangsaan Malaysia and a team of researchers studied SAP MR219, a SAP member induced by salinity stresses.Analysis of the SAP MR219 cDNA clone isolated from Oryza sativa var. MR219 revealed that its gene product ...

Michigan-focused academic drug discovery, development symposium presented by MichBio and the University Research Corridor

Michigan’s first event to showcase the state’s academic drug R&D activities will be held on September 9-10, 2015 and hosted by Michigan State University. The “Cutting Edge / Drug Discovery & Development in Michigan Symposium” will discuss the development, funding, partnering, and commercialization of new academic therapeutic...

G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD®

G-CON Manufacturing known for their innovative and prefabricated autonomous cleanroom PODs®, improves and expands their cell therapy product portfolio with miniPOD CTC and CTO. College Station, TX (PRWEB) July 29, 2015 G-CON Manufacturing, Inc., the leading prefabricated autonomous cleanroom POD® designer, manufacturer and supplier, announces the launch of their 2nd generation cell ther...

Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast

RICHMOND, Calif., July 29, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) today announced that the company will release its second quarter 2015 financial results after the market closes on Wednesday, August 5, 2015. The press release will be followed by a conference call at 5:00 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the comp...

Blocking a gene reduces fat

By blocking the expression of a certain gene in patients, University of Montreal researchers have contributed to the demonstration of great decreases in the concentration of triglycerides in their blood, even in various severe forms of hypertriglycer...

Takeda, DND to accelerate drug discovery for parasite infection

Biospectrum Geneva based Drugs for Neglected Diseases and Japan's Takeda have collaborated for a Lead Optimization Program [Read more]

Viamet to Present at Infectious Diseases Society for Obstetrics and Gynecology Annual Meeting

Phase 2a Data Demonstrate Advantages of Lead Agent VT-1161 over Current Antifungal Therapy Full Enrollment of Ongoing Phase 2b Trial in Recurrent Vulvovaginal Candidiasis Expected in Fourth Quarter of 2015 Viamet Pharmaceuticals, Inc. today announced that data from a Phase 2a study of VT-1161, the Company’s lead novel, oral antifungal...



Advertisement
 
Advertisement
 

News Quicklinks